Head-to-head · Value Score
Alan Meds vs Levers Health
Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, Levers Health a 75. Here's who gives you the honest lower price — and where each one bites back.
Alan Meds
#7 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameLevers Health
#130 · Grade C+ · Fair Price
Est. first month
From $123/mo (compounded)
Save ~91% vs brand-nameThe verdict
Alan Meds takes it on Value Score, 90 to 75 — an est. $99/mo first month, with no teaser step-up baked in. Levers Health isn't out of it: Patients interested in GLP-1 microdosing for longevity.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Alan Meds | Levers Health |
|---|---|---|
| Value Score | 90 (A) | 75 (C+) |
| Est. first month | $99/mo | From $123/mo (compounded) |
| Save vs brand-name | ~93% | ~91% |
| Semaglutide | $99/mo | From $123/mo (compounded) |
| Tirzepatide | $145/mo | From $296/mo (compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Alan Meds
Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.
Why it's a deal
- $99 flat semaglutide and a low $145 tirzepatide
- Available in all 50 states
- Offers an oral/sublingual route
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Newer operator with a thin public track record
Levers Health
Levers Health (Levers Health LLC) offers compounded semaglutide (from $247/mo) and tirzepatide (from $296/mo), plus low-dose/microdose GLP-1 for longevity.
Why it's a deal
- Named LLC entity
- Microdose GLP-1 option marketed for longevity
- Both semaglutide and tirzepatide available
The fine print
- No LegitScript or PCAB accreditation
- No physical address disclosed
- State availability not disclosed
- FAQ and terms pages return 404
- Above-average pricing ($247-$396/mo); tirzepatide any-dose plan is $396/mo (only the up-to-5mg low-dose plan is $296)
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Alan Meds is ranked on the Alan Meds alternatives board, and the same list for the other side is on alternatives to Levers Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.